UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of serum VIP and aCGRP during pulmonary exacerbation in cystic fibrosis: A longitudinal pilot study of patients undergoing antibiotic therapy

PloS one, 2023-05, Vol.18 (5), p.e0284511-e0284511

2023

Volltextzugriff (PDF)

Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index

PloS one, 2021-06, Vol.16 (6), p.e0252616-e0252616

2021

Volltextzugriff (PDF)

Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival

BMC cancer, 2023-02, Vol.23 (1), p.158-15, Article 158

2023

Volltextzugriff (PDF)

Effects of the Neuropeptides Pituitary Adenylate Cyclase Activating Polypeptide and Vasoactive Intestinal Peptide in Male Fertility

Medicina (Kaunas, Lithuania), 2024-04, Vol.60 (4), p.652

2024

Volltextzugriff (PDF)

The difference in knowledge and concerns between healthcare professionals and patients about genetic-related issues: A questionnaire-based study

PloS one, 2020-06, Vol.15 (6), p.e0235001-e0235001

2020

Volltextzugriff (PDF)

NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR

PloS one, 2013-10, Vol.8 (10), p.e77299-e77299

2013

Volltextzugriff (PDF)

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index

International journal of breast cancer, 2022-04, Vol.2022, p.4987912-10

2022

Volltextzugriff (PDF)

Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma

PloS one, 2013-05, Vol.8 (5), p.e62852

2013

Volltextzugriff (PDF)

Medication adherence to disease-modifying therapies among a cohort of Jordanian patients with relapsing-remitting multiple sclerosis: a multicentre cross-sectional study

The International journal of pharmacy practice, 2023-04, Vol.31 (2), p.198-205

2023

Volltextzugriff (PDF)

Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms

Chemical research in toxicology, 2017-10, Vol.30 (10), p.1767-1777

2017

Volltextzugriff (PDF)

Alpha Calcitonin Gene-related Peptide, Neuropeptide Y, and Substance P as Biomarkers for Diagnosis and Disease Activity and Severity in Multiple Sclerosis

CNS & neurological disorders drug targets, 2024-01, Vol.23 (4), p.512-524

2024

Volltextzugriff (PDF)

Knowledge and views about genetics: a public-based cross-sectional study

European journal of human genetics : EJHG, 2020-04, Vol.28 (4), p.417-423

2020

Volltextzugriff (PDF)

Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case–control study

Neurological sciences, 2022-04, Vol.43 (4), p.2621-2630

2022

Volltextzugriff (PDF)

Correlation of PKM2 Expression With HER2/neu and Additional Breast Cancer Biomarkers and its Prognostic Significance

Applied immunohistochemistry & molecular morphology, 2023-07, Vol.31 (6), p.363-370

2023

Volltextzugriff (PDF)

Self-Monitoring of Blood Glucose among Patients with Diabetes in Jordan: Perception, Adherence, and Influential Factors

Diabetes research and clinical practice, 2017-04, Vol.126, p.79-85

2017

Volltextzugriff (PDF)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.135-140

2018

Volltextzugriff (PDF)

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.23-29

2018

Volltextzugriff (PDF)

Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics

Omics (Larchmont, N.Y.), 2012-03, Vol.16 (3), p.113-122

2012

Volltextzugriff (PDF)

Abstract 6399: SP in relation to NK1R and Ki67 predicts survival in hormone receptor negative breast cancer

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.6399-6399

2022

Volltextzugriff (PDF)

Immunohistochemical expression of GRP78 in relation to angiogenesis markers VEGF-a and CD31 and other histopathological parameters in NSCLC

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e20500-e20500

2019

Volltextzugriff (PDF)

THE HDAC INHIBITOR SODIUM PHENYLBUTYRATE ENHANCES THE CYTOTOXICITY INDUCED BY 5-FLUOROURACIL, OXALIPLATIN, AND IRINOTECAN IN COLORECTAL CANCER CELL LINES

International journal of pharmacy and pharmaceutical sciences, 2018-01, Vol.10 (1), p.155

2018

Volltextzugriff (PDF)

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Clinical pharmacology: advances and applications, 2018-01, Vol.10, p.135

2018

Volltextzugriff (PDF)

GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study

Current cancer drug targets, 2023-01, Vol.23 (10), p.805-816

2023

Volltextzugriff (PDF)

Abstract 1188: Sodium phenylbutyrate has an antineoplastic effect and enhances the cytotoxicity of 5-fluorouracil and irinotecan in colorectal cancer cell lines

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1188-1188

2017

Volltextzugriff (PDF)

Healthcare providers' attitude and knowledge regarding medication use in breastfeeding women: a Jordanian national questionnaire study

Journal of obstetrics and gynaecology, 2018-02, Vol.38 (2), p.217-221

2018

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(22)

Publikationsform

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of serum VIP and aCGRP during pulmonary exacerbation in cystic fibrosis: A longitudinal pilot study of patients undergoing antibiotic therapy

Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index

Expression of substance P, neurokinin 1 receptor, Ki-67 and pyruvate kinase M2 in hormone receptor negative breast cancer and evaluation of impact on overall survival

Effects of the Neuropeptides Pituitary Adenylate Cyclase Activating Polypeptide and Vasoactive Intestinal Peptide in Male Fertility

The difference in knowledge and concerns between healthcare professionals and patients about genetic-related issues: A questionnaire-based study

NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index

Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma

Medication adherence to disease-modifying therapies among a cohort of Jordanian patients with relapsing-remitting multiple sclerosis: a multicentre cross-sectional study

Potential of Phenylbutyrate as Adjuvant Chemotherapy: An Overview of Cellular and Molecular Anticancer Mechanisms

Alpha Calcitonin Gene-related Peptide, Neuropeptide Y, and Substance P as Biomarkers for Diagnosis and Disease Activity and Severity in Multiple Sclerosis

Knowledge and views about genetics: a public-based cross-sectional study

Significance of serum VIP and PACAP in multiple sclerosis: an exploratory case–control study

Correlation of PKM2 Expression With HER2/neu and Additional Breast Cancer Biomarkers and its Prognostic Significance

Self-Monitoring of Blood Glucose among Patients with Diabetes in Jordan: Perception, Adherence, and Influential Factors

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Pramlintide, an antidiabetic, is antineoplastic in colorectal cancer and synergizes with conventional chemotherapy

Enhancing diagnosis, prognosis, and therapeutic outcome prediction of gliomas using genomics

Abstract 6399: SP in relation to NK1R and Ki67 predicts survival in hormone receptor negative breast cancer

Immunohistochemical expression of GRP78 in relation to angiogenesis markers VEGF-a and CD31 and other histopathological parameters in NSCLC

THE HDAC INHIBITOR SODIUM PHENYLBUTYRATE ENHANCES THE CYTOTOXICITY INDUCED BY 5-FLUOROURACIL, OXALIPLATIN, AND IRINOTECAN IN COLORECTAL CANCER CELL LINES

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

GRP78 is Overexpressed in Non-small Cell Lung Cancer Tissues and is Associated with High VEGF Expression in Squamous Cell Carcinoma: A Pilot Study

Abstract 1188: Sodium phenylbutyrate has an antineoplastic effect and enhances the cytotoxicity of 5-fluorouracil and irinotecan in colorectal cancer cell lines

Healthcare providers' attitude and knowledge regarding medication use in breastfeeding women: a Jordanian national questionnaire study

Suchergebnisse filtern